Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Innovative Approaches Proposed For Shanghai’s Health Reform

This article was originally published in PharmAsia News

Executive Summary

Shanghai's two universities - Fudan University and Jiaotong University - and the Shanghai Academy of Social Sciences will be separately drafting their version of healthcare reform for the city. The Shanghai Municipal Health Bureau will confirm the final draft adoption. Experts involved in crafting the universities' proposal revealed that it offers innovative ideas such as bringing in commercial insurance firms and setting up medical conglomerates according to regulatory policies. Social insurance implications include: the principle of reducing government subsidies, but providing legal protection and tax incentives; and allotting partial or full business operations to non-governmental departments. International insurers are not discounted, while conglomerates can comprise hospitals and specialist clinics, with different groups cooperating or competing among themselves. (Click here for more - Chinese Language)

You may also be interested in...



MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities

Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.

News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071904

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel